MENU
+Compare
DAWN
Stock ticker: NASDAQ
AS OF
Oct 17, 04:59 PM (EDT)
Price
$7.20
Change
-$0.27 (-3.61%)
Capitalization
765.17M

DAWN Day One Biopharmaceuticals Forecast, Technical & Fundamental Analysis

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more

DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for DAWN with price predictions
Oct 16, 2025

DAWN's RSI Indicator leaves overbought zone

The 10-day RSI Oscillator for DAWN moved out of overbought territory on October 06, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 instances where the indicator moved out of the overbought zone. In of the 17 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DAWN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DAWN broke above its upper Bollinger Band on October 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for DAWN entered a downward trend on October 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 65 cases where DAWN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 02, 2025. You may want to consider a long position or call options on DAWN as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DAWN just turned positive on October 15, 2025. Looking at past instances where DAWN's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

DAWN moved above its 50-day moving average on October 02, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for DAWN crossed bullishly above the 50-day moving average on October 03, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DAWN advanced for three days, in of 264 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.660) is normal, around the industry mean (24.455). P/E Ratio (0.000) is within average values for comparable stocks, (54.854). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.181). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (4.031) is also within normal values, averaging (352.090).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. DAWN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DAWN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

DAWN is expected to report earnings to rise 1.00% to -29 cents per share on November 10

Day One Biopharmaceuticals DAWN Stock Earnings Reports
Q3'25
Est.
$-0.29
Q2'25
Beat
by $0.06
Q1'25
Beat
by $0.07
Q4'24
Missed
by $0.17
Q3'24
Beat
by $0.70
The last earnings report on August 05 showed earnings per share of -28 cents, beating the estimate of -35 cents. With 327.64K shares outstanding, the current market capitalization sits at 765.17M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2000 Sierra Point Parkway
Phone
+1 650 484-0899
Employees
155
Web
https://www.dayonebio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEREX12.750.02
+0.16%
First Eagle Global Real Assets I
HSCYX31.31N/A
N/A
Hartford Small Company Y
TVRAX18.31N/A
N/A
NAA Allocation A
PSGQX34.80N/A
N/A
PGIM Jennison Focused Growth R6
PIIDX16.19N/A
N/A
Principal International Equity R-6

DAWN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAWN
1D Price
Change %
DAWN100%
-3.98%
DNLI - DAWN
49%
Loosely correlated
+2.51%
IDYA - DAWN
49%
Loosely correlated
-2.43%
RVMD - DAWN
49%
Loosely correlated
+0.24%
OCUL - DAWN
48%
Loosely correlated
+2.22%
NUVL - DAWN
46%
Loosely correlated
+0.87%
More